ChanTest develops and manufactures pharmaceutical products for cardiac risks.
Business Model:
Revenue: $17M
Employees: 51-200
ChanTest was acquired by
Charles River Laboratories International.
The acquisition happend on 2014-10-30.
Details of the transaction were not public
Address: 14656 Neo Pkwy
City: Cleveland
State: OH
Zip: 44128
Country: US
ChanTest develops and manufactures pharmaceutical products for cardiac risks.
Contact Phone:
+12163321665
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2007 | Venture Round | 1 | - |
Ampersand Capital Partners Ampersand Capital Partners |
8/2007 | Venture Round | 1 | - |
Ampersand Capital Partners Ampersand Capital Partners |
---|
Announced Date | Name | Price |
---|---|---|
2/2009 | Applied Cell Sciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|